Search clinical trials for: L-Dopa
Total 48 results
-
Emory UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingParkinson DiseaseUnited States
-
Charite University, Berlin, GermanyProf. Dr. Stefan M. Gold; Prof. Dr. Soyoung Q Park; Dr. Ulrike Grittner; Motognosis...RecruitingDepressive Disorder, MajorGermany
-
Vanderbilt University Medical CenterUniversity of Pittsburgh; Emory University; Rutgers University; University of Pittsburgh...RecruitingDepressive Disorder, Treatment-Resistant | Cognitive Decline | Late Life Depression | Gait Impairment | LevodopaUnited States
-
University Hospital, LilleInBrain PharmaRecruiting
-
VistaGen Therapeutics, Inc.Not yet recruitingParkinson Disease | Dyskinesia, Medication-Induced | L-Dopa Causing Adverse Effects in Therapeutic Use
-
The University of Texas Health Science Center,...National Institute on Drug Abuse (NIDA)RecruitingAlcohol Dependence | Substance Abuse | Cocaine Dependence | Opiate Dependence | Cocaine AbuseUnited States
-
Neurolixis SASMichael J. Fox Foundation for Parkinson's Research; CTC Clinical Trial Consultants... and other collaboratorsCompletedMedication-Induced DyskinesiaSweden
-
National Human Genome Research Institute (NHGRI)CompletedParkinson Disease | Gaucher DiseaseUnited States
-
Rion Inc.ProPharmaActive, not recruiting
-
MDD US Operations, LLC a subsidiary of Supernus...CompletedParkinson's Disease | Akinesia | Motor Symptoms | Hypomobility | Delayed Levodopa OnsetUnited States
-
New York State Psychiatric InstituteCompletedMajor Depressive Disorder | Dysthymia | Depression Not Otherwise Specified | Decreased Processing Speed | Decreased Gait SpeedUnited States
-
University GhentTerminated
-
Merck Sharp & Dohme LLCCompletedBrain Diseases | Central Nervous System Diseases | Parkinson Disease | Movement Disorders | Neurodegenerative Diseases
-
Novartis PharmaceuticalsCompletedDyskinesias | Drug-inducedUnited States, France, Germany, Italy
-
NovartisCompleted
-
Novartis PharmaceuticalsCompletedParkinson Disease | Parkinsonian Disorders | Movement Disorders | DyskinesiasSpain, France, Germany, Hungary, Italy, Canada, United States
-
Novartis PharmaceuticalsCompletedParkinson Disease | Dyskinesia, Drug-Induced | LevodopaItaly, United States, Australia, France, Germany, Canada
-
Novartis PharmaceuticalsCompletedParkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia AgentsSpain, United States, Austria, Switzerland, France, Germany, Italy, Hungary, Canada, Slovakia
-
Novartis PharmaceuticalsCompletedParkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia AgentsSpain, United States, Austria, Switzerland, France, Germany, Italy, Canada, Hungary, Slovakia
-
Impel PharmaceuticalsCompletedParkinson's DiseaseAustralia
-
Wen-Hann TanBaylor College of Medicine; University of California, San Francisco; Vanderbilt... and other collaboratorsCompleted
-
King's College LondonMedical Research CouncilCompleted
-
Astellas Pharma Europe B.V.World Health Information Science Consultants, LLCCompletedSystemic Fungal InfectionsUnited States
-
Biotie Therapies Inc.CompletedParkinson's DiseaseUkraine, Argentina, Romania, Canada, United States, Chile
-
Merck Sharp & Dohme LLCCompletedBrain Diseases | Central Nervous System Diseases | Parkinson Disease | Movement Disorders | Neurodegenerative Diseases
-
Bial - Portela C S.A.CompletedParkinson's Disease With Wearing-off Motor FluctuationsGermany
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Columbia UniversityCompleted
-
UCB PharmaUCB Trading (Shanghai) Co. Ltd.CompletedIdiopathic Parkinson's DiseaseChina
-
GlaxoSmithKlineCompletedParkinson DiseaseSpain, France, Bulgaria, United Kingdom, Germany, Hungary, Russian Federation, South Africa, Italy, Canada, Czechia, Poland, Romania, Ukraine
-
National Institute of Neurological Disorders and...Completed
-
University Hospital, ToulouseFrench Parkinson AssociationCompletedParkinson's DiseaseFrance
-
NovartisCompletedParkinson Disease | DyskinesiasItaly, Spain, France, Germany, Finland, Japan, Australia, Canada
-
Boston Children's HospitalCompletedAngelman SyndromeUnited States
-
Vanderbilt UniversityCompletedHealthy ParticipantsUnited States
-
NovartisCompletedEfficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease PatientsParkinson's Disease | L-dopa Induced DyskinesiaGermany
-
Centre for Addiction and Mental HealthCompleted
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
-
Bial - Portela C S.A.CompletedParkinson's DiseasePortugal
-
Bial - Portela C S.A.CompletedParkinson's DiseasePortugal
-
University of TorontoMichael J. Fox Foundation for Parkinson's ResearchUnknownParkinson's DiseaseCanada
-
Khon Kaen UniversityCompleted
-
University Hospital, Clermont-FerrandCompleted
-
GlaxoSmithKlineCompletedParkinson's Disease | Parkinson DiseaseJapan
-
PfizerVicuron PharmaceuticalsCompleted
-
National Institute of Neurological Disorders and...Completed
-
National Institute of Neurological Disorders and...Completed
-
Rottapharm SpainCompletedParkinson's Disease, IdiopathicSpain
-
National Institute of Neurological Disorders and...Completed